Our call of the day, from Andrew Milligan, head of global strategy at Standard Life Investments , says some rather fickle money is backing the stock market gains we’ve seen since Christmas. See full story.

Tilray makes richest deal yet in effort to jump into U.S. CBD market

Marijuana company Tilray Inc. announced its most expensive acquisition to date early Wednesday, agreeing to spend more than $300 million for a company that claims to be the world’s largest hemp food maker. See full story.

Trump suggests trade-deal flexibility: March 1 tariff deadline is ‘not a magical date’

President Donald Trump gave his firmest indication yet that the U.S. may not increase tariffs on Chinese goods on March 1, as scheduled, despite statements by his top trade official that the U.S. should stick to a firm deadline. See full story.

9 stocks with dividend yields over 4% in a sector that often beats the broader market

REITs outperformed the S&P 500 last year and so far in 2019. See full story.

Five reasons emerging-markets stocks could outperform U.S. stocks for several years

Emerging-markets stocks have been in the doldrums, but that may be about to change. See full story.


You’ve heard of these companies, but chances are you haven’t heard of the cities and towns they call home. See full story.

Providing critical information for the U.S. trading day. Subscribe to MarketWatch’s free Need to Know newsletter. Sign up here.